Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anesthesia maintenance regimens in retrosigmoid microvascular decompression
ChiCTR2500102774Phase 4Recruiting
- Sponsor
- Army Medical Center of PLA
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexmedetomidine, sevoflurane and propofol in Neurovascular compression syndrome (NVCS) (3 arms), sponsored by Army Medical Center of PLA. Primary endpoints: Optic nerve sheath diameter and Postoperative nausea and vomiting. Started May 2025; status: recruiting.
02
Drugs
dexmedetomidinesevofluranepropofol
03
Conditions
Neurovascular compression syndrome (NVCS)
Beyond the preview
Go deeper on ChiCTR2500102774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500102774.